4th Quarter - Report

W STRATEGIES, LLC for GLAXOSMITHKLINE

Period 4th Quarter 2017 Filed Jan 19, 2018 Signed by Darren Willcox

Official filing
Firm
W STRATEGIES, LLC
Client
GLAXOSMITHKLINE
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.1/S.1: Tax Cuts and Jobs Act. H.R.394: Restoring Access to Medication Act of 2017.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1 (115th), H.R. 1 (115th), H.R. 394 (115th)

Health Issues HCR

FDA OTC Monograph reform. H.R.3922: CHAMPIONING HEALTHY KIDS Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3922 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.